Germany's premier gathering for the biopharma community dedicated to propelling bioprocessing innovation and market expansion.
Germany ranks fourth globally in biopharmaceuticals, with over 650 biotechnology companies. Its collaboration among industry, government, and research sectors, along with bioregions, propels the sector forward. The increasing prevalence of chronic diseases and an aging population have boosted demand for biologic drugs, leading to an 8% annual growth in prescriptions. Recent advancements made by Calidi Biotherapeutics, Eleva Biologics and Roche underscore Germany's appeal, thanks to its strategic location, skilled workforce, advanced infrastructure, and government incentives.
Biologics Manufacturing Germany 2024 will delve into advancements in biomanufacturing and examine how rising operational complexity and uncertainty impact long-term decision-making. Topics will include risk mitigation, regulatory changes, and CMO partner selection, especially in light of automation, AI, and sustainability. These discussions are crucial for stakeholders in the biologics manufacturing industry, providing valuable insights on navigating challenges and making informed decisions in a complex and dynamic environment.
CONFERENCE LEARNING POINTS
Limited Super (until 17th May 2024)
GBP 850
Limited Special (until 19th July 2024)
GBP 1,050
Early Bird (until 20th September 2024)
GBP 1,250
Standard Price
GBP 1,450
*END-USER PRICING IS APPLICABLE to :
Company Profiles: Biopharma, BIG Pharmas, CMO's, Europe Academic & Research Institutes
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
Limited Super (until 17 May 2024)
GBP 2,050
Limited Special (until 19 July 2024)
GBP 2,250
Early Bird (until 20 September 2024)
GBP 2,450
Standard Price
GBP 2,650
*SOLUTION PROVIDER PRICING IS APPLICABLE to
Company Profile: Service & Solution Providers, Europe/UK and International biopharma, CDMO's, Academics and Research Institutes
Job Profiles: Business Development, Marketing & Sales
Limited Super (until 17th May 2024)
GBP 850
Limited Special (until 19th July 2024)
GBP 1,050
Early Bird (until 20th September 2024)
GBP 1,250
Standard Price
GBP 1,450
*END-USER PRICING IS APPLICABLE to :
Company Profiles: Biopharma, BIG Pharmas, CMO's, Europe Academic & Research Institutes
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
Limited Super (until 17 May 2024)
GBP 2,050
Limited Special (until 19 July 2024)
GBP 2,250
Early Bird (until 20 September 2024)
GBP 2,450
Standard Price
GBP 2,650
*SOLUTION PROVIDER PRICING IS APPLICABLE to
Company Profile: Service & Solution Providers, Europe/UK and International biopharma, CDMO's, Academics and Research Institutes
Job Profiles: Business Development, Marketing & Sales
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2024 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.
Germany's premier gathering for the biopharma community dedicated to propelling bioprocessing innovation and market expansion.
IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.
IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.